Speakers Share

Dr. Roziana Ariffin

Consultant Genetic Pathologist HTA KL, Sunway Medical Centre & Prince Court Medical Center

BIOGRAPHY
Dr. Aparna Dhar

Core Diagnostics, Head of Department of Medical Genetics and Genetics Counseling

BIOGRAPHY
Professor Ahwon Lee

Department of Hospital Pathology, St. Mary's Hospital, Seoul

BIOGRAPHY
Dr. Daren Teoh Choon Yu

Consultant Oncologist, KPJ Sabah Specialist Hospital (BMed Sci, BMBS Nottingham University, UK , MRCP (UK), FRCR (UK), CCST (UK))

BIOGRAPHY

September 12, 2020 02:00 PM SGT

APJ Oncology User Meeting: Advances in Molecular Testing - Women's Cancer

Next-generation sequencing has revolutionized molecular testing. Join us and our industrial partners in an exclusive discussion on key topics in Women's Health. Exploring the clinical importance molecular testing has provided to support patient care. Together, we invite experts to share their thoughts and experience in this field. The session will start at 2pm SGT (11:30am IST, 4pm AEST) and agenda as below:

Time (SGT)	Topics	Speakers
14:00	Genetic testing: Impact on Patient Care	Dr Aparna Dhar (India)
14:15	Key considerations in setting up BRCA testing	Dr Lee AW (South Korea)
14:30	Beyond BRCA & PARPi in Ovarian Cancer - How Testing Can Change Your Life Sponsored by AstraZeneca	Dr Roziana Ariffin (Malaysia)
14:45	PIK3CA mutation in HR+/HER2- BC – Role of PI3K-inhibitor Sponsored by Novartis	Dr Daren Teoh (Malaysia)
15:00	Panel Discussion and Q&A (30mins)	All speakers

There will be a panel discussion after the presentation and opportunity to interact with the speakers as well as a live Q&A session. Participants are encouraged to come with questions.

This is one of the first APJ oncology user meeting, which will be held as part of OncomineWorld virtual environment. In this virtual environment, you will have the opportunity to:

Explore the NGS Oncology Application Hall and its many specialty booth-labs including immuno-oncology research, emerging NSCLC biomarkers, liquid biopsy, PIK3CA research testing, and hemato-oncology research.

Visit our virtual lab to experience the new world of easy and fast NGS - the Ion Torrent Genexus System - and become familiar with our well-proven workhorse, the Ion Torrent GeneStudio system, with its many applications.

Visit the Precision Oncology Hall to access videos, posters and more on the future potential of NGS in the clinic.

Speakers

Dr. Roziana Ariffin

Consultant Genetic Pathologist HTA KL, Sunway Medical Centre & Prince Court Medical Center
BIOGRAPHY
Dr. Aparna Dhar

Core Diagnostics, Head of Department of Medical Genetics and Genetics Counseling
BIOGRAPHY
Professor Ahwon Lee

Department of Hospital Pathology, St. Mary's Hospital, Seoul
BIOGRAPHY
Dr. Daren Teoh Choon Yu

Consultant Oncologist, KPJ Sabah Specialist Hospital (BMed Sci, BMBS Nottingham University, UK , MRCP (UK), FRCR (UK), CCST (UK))
BIOGRAPHY

Agenda Share

Download Agenda

ondemand

SEP 12, 2020 2:45 PM +08

PIK3CA mutation in HR+/HER2- BC - Role of PI3K-inhibitor

Dr. Daren Teoh Choon Yu

Consultant Oncologist, KPJ Sabah Specialist Hospital (BMed Sci, BMBS Nottingham University, UK , MRCP (UK), FRCR (UK), CCST (UK))
BIOGRAPHY

In this presentation, we will discuss:

- Prevalence & prognosis of PIK3ca mutation in HR+/HER2- BC

- Current SOC for MBC

- Summary of SOLAR-1 study (clinical evidence of pi3k-i targeting this specific mutation)

- When to perform testing & clinical consideration

SEE ABSTRACT HIDE ABSTRACT
SEP 12, 2020 2:30 PM +08

Beyond BRCA & PARPi - How Testing Can Change Your Life

Dr. Roziana Ariffin

Consultant Genetic Pathologist HTA KL, Sunway Medical Centre & Prince Court Medical Center
BIOGRAPHY

In the advent of targeted therapy in ovarian cancer, BRCA gene & “BRCA-ness” genes play a pivotal role in identifying the right patient for the right treatment. In this talk, we will details on the Who why when & how of BRCA testing as well as looking into the horizon of genes beyond BRCA such as HRR & HRD which can benefit a patient with ovarian cancer.

SEE ABSTRACT HIDE ABSTRACT
SEP 12, 2020 2:15 PM +08

Key considerations in setting up BRCA testing

Professor Ahwon Lee

Department of Hospital Pathology, St. Mary's Hospital, Seoul
BIOGRAPHY

In this talk, Professor Lee will share with us her precious experience and her perspective of setting up NGS BRCA test in her lab.

SEE ABSTRACT HIDE ABSTRACT
SEP 12, 2020 2:00 PM +08

Genetic testing: Impact on Patient Care

Dr. Aparna Dhar

Core Diagnostics, Head of Department of Medical Genetics and Genetics Counseling
BIOGRAPHY

As healthcare professionals we know genetic testing for hereditary cancers is more than a simple blood draw. It is a very personal and emotional decision. The results can be lifesaving not just for the patient but their family members as well. While we know genetic testing helps in identifying those who could have a genetic predisposition to cancer, managing and potentially reducing their risk of cancer; one of the biggest struggles surrounding genetic testing is not knowing who and how to screen?

The next step is often marred by the medical community at large. While any provider can order the blood/saliva test, patients often don’t receive adequate genetic counseling to help them grasp the potential emotional, physical and familial impact of genetic testing. It becomes important to understand how it could impact patients and potentially their families. In addition, interpreting these tests is relatively complex, and genetic testing isn’t just a “yes” or “no” answer. When genetic testing was introduced it was pretty straight forward; BRCA1 and BRCA2 testing. Today we are not limited to just BRCA testing. There are a lot of subtleties, but if you don’t fully understand or how to manage it, that’s a problem!

Through my presentation I’ll illustrate how a simple, “blood test” can impact the life of a patient and their family but also change the face of healthcare, and what medical practitioners should know about genetic testing.

SEE ABSTRACT HIDE ABSTRACT